# ImpactLife – FDA Inspection, Oct 6, 2017

Source: https://www.keypedia.com/records/fda_inspections/impactlife/70a0b0b7-7c21-4f02-b7a1-351e91850635
Source feed: FDA_Inspections

> FDA inspection 1030109 of ImpactLife, October 06, 2017. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1030109
- Company Name: ImpactLife
- Inspection Date: 2017-10-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1240356 - 2024-05-30
- FDA Inspection 1114603 - 2019-12-19
- FDA Inspection 948008 - 2015-10-09
- FDA Inspection 854420 - 2013-11-05
- FDA Inspection 776356 - 2012-04-03

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/john-a-iwen/b71cb474-8485-416e-a534-ffaed0319625)

Company: https://www.keypedia.com/companies/impactlife/c495b13d-4233-4d21-b530-4e1df39ce388

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d